SCHEMBL7790147

SCHEMBL7790147

CCc1cc(OC2CCCC(Cc3cccc(OC(F)(F)F)c3)(NCC(O)C(F)(F)F)C2)ccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CETP P11597 19/20 0.49
SCN9A Q15858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567860 0.94 CETP (0.50) CETP
SCHEMBL6274752 0.91 CETP (0.41) CETP
SCHEMBL7790102 0.89 CETP (0.49) CETP
SCHEMBL6276333 0.86 CETP (0.48) CETPSCN9A
SCHEMBL5669788 0.83 CETP (0.35) CETP
SCHEMBL5669311 0.82 CETP (0.41) CETP
SCHEMBL5669779 0.82 CETP (0.42) CETP
SCHEMBL6571577 0.81 CETP (0.44) CETP
SCHEMBL5670064 0.80 CETP (0.51) CETP
SCHEMBL5668807 0.76 CETP (0.46) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010018446-A1 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity G.D. SEARLE & CO. (US) 2001-08-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010018446-A1 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity CETP, DBI, MTTP CETP 1/4885SCN9A 2629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.